Resources
The AMA has collected more than 400 educational and other resources to provide evidence-based recommendations for physicians and policymakers.
The AMA has collected more than 400 educational and other resources to provide evidence-based recommendations for physicians and policymakers.
The first in this series—Science to Medicine: Medication Treatment for Opioid Use Disorder (OUD)—offers quick, targeted information on how to get started offering OUD treatment medications and other recovery support services in your practice. Learn about the science behind it, hear how your peers have implemented it, find resources to get started, and propose a topic for the next Science to Medicine series.
Learn how medications can be used to treat substance use disorders, sustain recovery and prevent overdose.
This [Treatment Improvement Protocol] reviews three Food and Drug Administration-approved medications for opioid use disorder treatment—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support people in recovery.
Listen and learn from nationally recognized experts in these 15-minute podcasts about the importance and effectiveness of starting buprenorphine treatment for opioid use disorder (OUD) in emergency departments. Hospital leaders receive research-backed advice on the technology tools, clinical evidence, and referral networks that support this safe and effective first-line treatment in the ED – and how this research has been translated into action.
Summarizes how opioid use disorder is diagnosed using the DSM-5 assessment criteria, how to discuss this diagnosis with patients, and how to treat opioid use disorder. CE available.
Shares benefits of buprenorphine for treating opioid use disorder, including its versatility for initiation in multiple clinical settings and effectiveness in reducing illicit opioid use. Information on naltrexone and methadone can be found in the Assessing and Addressing Opioid Use Disorder module, and additional trainings will be developed.
This guideline provides recommendations for clinicians providing pain care, including those prescribing opioids, for outpatients aged ≥18 years.
This issue brief seeks to dispel myths and provide practical strategies to save lives and reduce harms from drug-related overdose.
The AMA Substance Use and Pain Care Task Force urges physicians and other health care professions to continue taking action to help reverse the nation’s drug overdose epidemic—and the Task Force also calls on policymakers to take specific steps to remove barriers to evidence-based care for patients with pain and those with a substance use disorder.
Learn More Join the AMA today and help us lead the effort
to reverse the nation’s opioid epidemic.